Approaching a Breaking Point (RealMoney.com $)
The market may soon break out of its range, and the likely direction is down.
08:30AM 05/22/09
Gap Insiders Sell $34 Million Worth
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
11:36AM 04/21/09
Health Winners & Losers: Altus
Shares of the company drop after announcing late-stage trial results that disappoint the Street.
05:59PM 08/12/08
Altus Shares Plummet on Drug Trial
Cystic Fibrosis candidate Trizytek performed better than a placebo in trials, but perhaps not as much as the FDA wanted.
02:20PM 08/12/08
TheStreet.com Rates 37 New ETFs
Two Vanguard bond funds receive top marks. Two HealthShares funds don't.
07:09AM 05/28/08
Thursday's Health Winners & Losers
EPIX plunges after ending development of its depression drug.
03:36PM 03/20/08
Tuesday's Health Winners & Losers
Omrix Biopharmaceuticals climbs on preliminary earnings results.
04:44PM 02/05/08
This week, Adam responds to reader inquiries about Xoma, Vanda and Onyx.
10:31AM 01/19/08
Biotech Notebook: Genitope, Amicus
Failing a phase III trial is never a good thing. Don't believe a CEO's attempt to spin it otherwise.
01:44PM 12/21/07
Thursday's Winners & Losers: Bear Stearns Shares Bear Up Well
The brokerage's stock finishes in positive territory despite a big quarterly loss.
05:51PM 12/20/07
Thursday's Health Winners & Losers
Altus got its hormone drug, but gave up 40% in the market.
02:16PM 12/20/07
Biotech Trial Dates to Watch in '08
Myriad Genetics and Dendreon are among those with major clinical trials next year.
12:06PM 12/12/07
These 10 Biotechs Have Drugs Near Finish Line
Here's a list of stocks set to report phase III trial results.
11:28AM 07/20/07
Feuerstein's Biotech-Stock Mailbag
Adam reveals the stocks he follows in his own model portfolio.
10:20AM 07/14/07
Connect with TheStreet